📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A gene signature associated with PTEN activation defines good prognosis intermediate risk prostate cancer cases. (2018)

First Author: Ong CW

Attributed to: The central importance of CXCL8 signaling to inflammatory-based tumour initiation and invasive prostate carcinoma. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/cjp2.94

PubMed Identifier: 29665325

Publication URI: http://europepmc.org/abstract/MED/29665325

Type: Journal Article/Review

Volume: 4

Parent Publication: The journal of pathology. Clinical research

Issue: 2

ISSN: 2056-4538